Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole, Quetiapine, and Ziprasidone in First-episode Psychosis
NCT02534363Phase 4Completed
- Sponsor
- Fundación Marqués de Valdecilla
- Start
- Oct 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole, quetiapine (extended-release tablet, brand name: Bipresso), ziprasidone in schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder (BPD), sponsored by Fundación Marqués de Valdecilla. Started Oct 2005; status: completed.
02
Drugs
aripiprazolequetiapine (extended-release tablet, brand name: Bipresso)ziprasidone
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorderbrief psychotic disorder (BPD)
Beyond the preview
Go deeper on NCT02534363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534363.